LONDON, UK: Syncona Ltd, a leading healthcare company, announced that Blackstone Life Sciences has entered into a strategic collaboration and financing agreement with Syncona portfolio company Autolus Therapeutics. The key terms of the financing agreement are set out below: · $250 million transaction: $100 million immediate equity investment and up to $150 million in product…